Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

BACKGROUND: Trabectedin is an antineoplastic agent used for patients with soft tissue sarcoma (STS) who fail standard-of-care treatment. Real-world data of its performance is scarce. This study evaluates the safety and effectiveness of trabectedin for patients with advanced STS who were treated at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Angarita, Fernando A., Cannell, Amanda J., Abdul Razak, Albiruni R., Dickson, Brendan C., Blackstein, Martin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719676/
https://www.ncbi.nlm.nih.gov/pubmed/26786213
http://dx.doi.org/10.1186/s12885-016-2054-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719676/
https://www.ncbi.nlm.nih.gov/pubmed/26786213
http://dx.doi.org/10.1186/s12885-016-2054-2

Ejemplares similares